Study S000589

A Biomarker-targeted Clinical Trial to Optimize Treatment for Patients With Chronic Kidney Disease: A Prospective, Randomized, Open-Label, Parallel-Group, Multicenter Study

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07239570
Acronym: CKD-bioMatch
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: NONE
Status: RECRUITING
Enrollment: 125
Start: 2025-06-20
Primary completion: 2028-06
Lead sponsor: Peter Rossing
Conditions: Chronic Kidney Disease(CKD)
Interventions: DRUG:Dapagliflozin; DRUG:Semaglutide; DRUG:Finerenone
Results posted: FALSE
Individual participant data sharing: NO
Secondary identifiers: NIH:2023

Registered primary outcomes

Chronic eGFR slope [From week 26 to 104]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.